COPRO-HOLDINGS. Co., Ltd. Logo

COPRO-HOLDINGS. Co., Ltd.

Dispatches technical personnel to Japan's construction & plant industries.

7059 | T

Overview

Corporate Details

ISIN(s):
JP3302000009
LEI:
Country:
Japan
Address:
名古屋市中村区名駅三丁目28番12号 大名古屋ビルヂング25階
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

COPRO-HOLDINGS. Co., Ltd. is a holding company specializing in temporary staffing and technical personnel dispatch services. The company primarily focuses on dispatching skilled engineers and technicians to clients in the construction and industrial plant industries throughout Japan. Its service offerings also extend to machine design, development support, and System Engineering Services (SES). As the administration and management arm of the Copro Group, the firm provides comprehensive human resource solutions for specialized technical fields.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-06-20 09:02
Post-Annual General Meeting Information
臨時報告書
Japanese 21.4 KB
2025-06-19 09:02
Governance Information
内部統制報告書-第19期(2024/04/01-2025/03/31)
Japanese 22.7 KB
2025-06-19 09:01
Registration Form
確認書
Japanese 8.2 KB
2025-06-19 09:00
Annual Report
有価証券報告書-第19期(2024/04/01-2025/03/31)
Japanese 1.1 MB
2025-06-13 09:30
Regulatory News Service
臨時報告書
Japanese 18.4 KB
2024-11-19 08:06
Regulatory News Service
臨時報告書
Japanese 19.7 KB
2024-11-13 05:03
Report Publication Announcement
確認書
Japanese 8.2 KB
2024-11-13 05:02
Interim Report
半期報告書-第19期(2024/04/01-2025/03/31)
Japanese 215.1 KB
2024-09-02 06:30
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 25.4 KB
2024-08-01 04:31
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 30.1 KB
2024-06-24 06:08
Post-Annual General Meeting Information
臨時報告書
Japanese 22.4 KB
2024-06-24 06:07
Governance Information
内部統制報告書-第18期(2023/04/01-2024/03/31)
Japanese 22.2 KB
2024-06-24 06:06
Registration Form
確認書
Japanese 8.2 KB
2024-06-24 06:05
Annual Report
有価証券報告書-第18期(2023/04/01-2024/03/31)
Japanese 1.1 MB
2024-04-12 10:00
Share Issue/Capital Change
臨時報告書
Japanese 39.5 KB

Automate Your Workflow. Get a real-time feed of all COPRO-HOLDINGS. Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for COPRO-HOLDINGS. Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for COPRO-HOLDINGS. Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Advancing high-grade copper and precious metal projects from discovery to production.
Canada
COR
Cantargia Logo
Develops antibody treatments targeting IL1RAP for cancer and autoimmune/inflammatory diseases.
Sweden
CANTA
Captor Therapeutics S.A. Logo
Developing TPD therapeutics for oncology and autoimmune diseases with its Optigrade™ platform.
Poland
CTX
Cardiff Oncology, Inc. Logo
Clinical-stage biotech developing a PLK1 inhibitor to treat resistant cancers.
United States of America
CRDF
Cardio Diagnostics Holdings, Inc. Logo
AI-powered epigenetic and genetic tests for early detection of heart disease risk.
United States of America
CDIO
Cardiol Therapeutics Inc. Logo
Develops oral cannabidiol therapies for inflammatory and fibrotic heart diseases.
United States of America
CRDL
CareDx, Inc. Logo
Precision diagnostics and surveillance solutions for the organ transplant journey.
United States of America
CDNA
Offers one-stop BPO, CRM, and staffing for admin, manufacturing, and logistics.
Japan
6070
Caris Life Sciences, Inc. Logo
Pioneering precision cancer care via AI-powered molecular profiling and diagnostics.
United States of America
CAI
Carna Biosciences, Inc. Logo
Develops kinase inhibitor drugs for oncology/autoimmune diseases & offers discovery support services.
Japan
4572

Talk to a Data Expert

Have a question? We'll get back to you promptly.